ProCE Banner Activity

Short-Course Glecaprevir/Pibrentasvir Plus Ezetimibe Prevents HCV Transmission During Transplantation From HCV-Infected Donors

Slideset Download
Conference Coverage
This small study showed that a short preemptive course of GLE/PIB + EZE given pre- and post-transplant prevented HCV transmission in all HCV-uninfected patients who received organs from HCV-infected donors.

Released: November 16, 2019

Expiration: November 14, 2020

No longer available for credit.

Share

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

AbbVie

Gilead Sciences, Inc.

Intercept Pharmaceuticals